Works matching IS 13520504 AND DT 2015 AND VI 22 AND IP 12

Results: 15

Changing 14-year trends in the epidemiology of hepatitis B virus infection in rural and urban Central-Eastern European areas.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 1061, doi. 10.1111/jvh.12420

By:

Genowska, A.;
Jamiołkowski, J.;
Rodakowska, E.;
Fryc, J.;
Kozela, M.;
Pająk, A.

Publication type:

Article

Direct costs of first-generation protease inhibitors for the treatment of genotype 1 chronic hepatitis C viral infection.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 974, doi. 10.1111/jvh.12421

By:

Sethi, N.;
Tapper, E. B.;
Vong, A.;
Sethi, S.;
Rourke, M.;
Afdhal, N. H.

Publication type:

Article

Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 992, doi. 10.1111/jvh.12427

By:

Ogawa, E.;
Furusyo, N.;
Dohmen, K.;
Kajiwara, E.;
Kawano, A.;
Nomura, H.;
Takahashi, K.;
Satoh, T.;
Azuma, K.;
Nakamuta, M.;
Koyanagi, T.;
Kotoh, K.;
Shimoda, S.;
Hayashi, J.

Publication type:

Article

T- and B-cell responses and previous exposure to hepatitis B virus in 'anti- HBc alone' patients.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 1068, doi. 10.1111/jvh.12428

By:

Wang, Q.;
Sachse, P.;
Semmo, M.;
Lokhande, M.;
Montani, M.;
Dufour, J.‐F.;
Zoulim, F.;
Klenerman, P.;
Semmo, N.

Publication type:

Article

Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 1020, doi. 10.1111/jvh.12429

By:

Doyle, J. S.;
Deterding, K.;
Grebely, J.;
Wedemeyer, H.;
Sacks‐Davis, R.;
Spelman, T.;
Matthews, G.;
Rice, T. M.;
Morris, M. D.;
McGovern, B. H.;
Kim, A. Y.;
Bruneau, J.;
Lloyd, A. R.;
Page, K.;
Manns, M. P.;
Hellard, M. E.;
Dore, G. J.

Publication type:

Article

Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 977, doi. 10.1111/jvh.12448

By:

Younossi, Z.M.;
Elsheikh, E.;
Stepanova, M.;
Gerber, L.;
Nader, F.;
Stamm, L.M.;
Brainard, D.M.;
McHutchinson, J.G.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. i, doi. 10.1111/jvh.12329
Publication type:: Article

Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 983, doi. 10.1111/jvh.12465

By:

Burchill, M. A.;
Golden‐Mason, L.;
Wind‐Rotolo, M.;
Rosen, H. R.

Publication type:

Article

Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 1033, doi. 10.1111/jvh.12430

By:

Huang, Q.‐t.;
Huang, Q.;
Zhong, M.;
Wei, S.‐s.;
Luo, W.;
Li, F.;
Yu, Y.‐h.

Publication type:

Article

Association of IFNL3 and IFNL4 polymorphisms with liver-related mortality in a multiracial cohort of HIV/HCV-coinfected women.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 1055, doi. 10.1111/jvh.12431

By:

Sarkar, M.;
Aouzierat, B.;
Bacchetti, P.;
Prokunina‐Olsson, L.;
French, A.;
Seaberg, E.;
O'Brien, T. R.;
Kuniholm, M. H.;
Minkoff, H.;
Plankey, M.;
Strickler, H. D.;
Peters, M. G.

Publication type:

Article

Disease burden of chronic hepatitis C among immigrants in Canada.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 1043, doi. 10.1111/jvh.12432

By:

Chen, W.;
Krahn, M.

Publication type:

Article

The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 1002, doi. 10.1111/jvh.12433

By:

Boursier, J.;
Ducancelle, A.;
Vergniol, J.;
Veillon, P.;
Moal, V.;
Dufour, C.;
Bronowicki, J.‐P.;
Larrey, D.;
Hézode, C.;
Zoulim, F.;
Fontaine, H.;
Canva, V.;
Poynard, T.;
Allam, S.;
De Lédinghen, V.

Publication type:

Article

Serum HBsAg kinetics and usefulness of interferon-inducible protein 10 serum in HBeAg-negative chronic hepatitis B patients treated with tenofovir disoproxil fumarate.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 1079, doi. 10.1111/jvh.12434

By:

Papatheodoridis, G.;
Triantos, C.;
Hadziyannis, E.;
Zisimopoulos, K.;
Georgiou, A.;
Voulgaris, T.;
Vlachogiannakos, I.;
Nikolopoulou, V.;
Manolakopoulos, S.

Publication type:

Article

A phase 1, randomized, dose-ranging study of GS-5816, a once-daily NS5A inhibitor, in patients with genotype 1-4 hepatitis C virus.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 1011, doi. 10.1111/jvh.12435

By:

Lawitz, E.;
Freilich, B.;
Link, J.;
German, P.;
Mo, H.;
Han, L.;
Brainard, D. M.;
McNally, J.;
Marbury, T.;
Rodriguez‐Torres, M.

Publication type:

Article

Antiviral therapy in chronic hepatitis E: a systematic review.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 965, doi. 10.1111/jvh.12403

By:

Peters van Ton, A. M.;
Gevers, T. J. G.;
Drenth, J. P. H.

Publication type:

Article